7 completed, 2 active not recruiting, 2 recruiting, 1 enrolling by invitation. 5 Phase 3, 4 Phase 4, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Recruiting 1 |
| Phase 4 | 4 | Active not recruiting 2, Enrolling by invitation 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
Follow Infanrix: new trials by email Literature Review of Infanrix trials Research Report on Infanrix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ESCUDDO Long Term Follow Up Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Phase 4 | Enrolling by invitation | National Cancer Institute (NCI) | 13700 | 2026-08-11 | 2026-09-22 |
| BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies Multivalent Group B streptococcus vaccine, Placebo, Infanrix hexa - Healthy | Phase 3 | Recruiting | Pfizer | 6000 | 2025-08-25 | 2026-10-27 |
| Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial Biopsy, Biospecimen Collection, Computed Tomography - Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | Recruiting | Mayo Clinic | 78 | 2024-11-12 | 2026-10-02 |
| Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 5000 | 2022-03-01 | 2026-10-22 |
| Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 27945 | 2017-11-29 | 2025-09-04 |
| Duration of Protection: GSK DTaP Vaccines Infanrix, Pediarix, Kinrix - Diphtheria, Acellular Pertussis | Completed | GlaxoSmithKline | 1 | 2015-02-01 | 2015-11-02 | |
| Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants Infanrix hexa, Pediarix, ActHIB - Poliomyelitis, Diphtheria | Phase 3 | Completed | GlaxoSmithKline | 585 | 2014-04-16 | 2019-11-27 |
| Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old Cervarix, Priorix, Infanrix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 148 | 2012-10-15 | 2020-04-10 |
| Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. Infanrix™/Hib, Infanrix, Hiberix - Tetanus, Diphtheria | Phase 3 | Completed | GlaxoSmithKline | 660 | 2007-01-03 | 2018-06-06 |
| Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines SB213503 lot 1, SB213503 lot 2, SB213503 lot 3 - Tetanus, Acellular Pertussis | Phase 3 | Completed | GlaxoSmithKline | 4209 | 2005-01-06 | 2020-02-05 |
| Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. INFANRIX, BOOSTRIX, HAVRIX - Acellular Pertussis, Tetanus | Phase 4 | Terminated | GlaxoSmithKline | 720 | 2003-05-01 | 2016-09-07 |
| Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. Human Rotavirus Vaccine - two different formulations, Prevnar, IPOL - Infections, Rotavirus | Phase 2 | Completed | GlaxoSmithKline | 529 | 2000-11-01 | 2016-09-16 |
| DTaP and Apnea/Bradycardia in Preterm Infants Infanrix, Pediatrix - Prolonged Apnea, Prolonged Bradycardia | Not applicable | Completed | American SIDS Institute | 191 | 2000-09-01 | 2007-06-05 |
Diphtheria (5) · Tetanus (5) · Papillomavirus Infections (3) · Apnea (1) · Bradycardia (1) · Haemophilus Infections (1) · Hepatitis B (1) · Poliomyelitis (1) · Premature Birth (1) · Rotavirus Infections (1)
GlaxoSmithKline (7) · National Cancer Institute (NCI) (3) · American SIDS Institute (1) · Mayo Clinic (1) · Pfizer (1)
United States (5) · Costa Rica (3) · Mexico (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · China (1) · Colombia (1) · Finland (1) · Japan (1) · Netherlands (1) · Panama (1) · Philippines (1) · South Africa (1)
Aimee R Kreimer (2) · Aimee Kreimer (1) · Betty McEntire, PhD (1) · Matthew S. Block, MD, PhD (1) · Tracy Carbone, MD (1)
PMID 41276263, PMID 18450851, PMID 28506516, PMID 32078808, PMID 33857679, PMID 34857420, PMID 41337735